Xing‐Jie Liang
Xing‐Jie Liang publishes mostly in Molecular Biology, Biomedical Engineering and Biomaterials, on topics such as Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery and RNA Interference and Gene Delivery.
- World rank
- #10,531 of 7,710,434 ranked researchers
- Rank in China
- #556 of 978,568
- Works
- 657
- Citations
- 46k
- Citations per work
- 69.7
What does Xing‐Jie Liang research?
Xing‐Jie Liang's work is mostly in Materials Science (22%), Biochemistry, Genetics and Molecular Biology (21%), Engineering (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences26640.5%
- Materials Science14221.6%
- Engineering12418.9%
- Everything else20431.1%
- Life Sciences16024.4%
- Health Sciences264.0%
- Medicine264.0%
- 1Molecular Biology21% of their works
- 2Biomedical Engineering19% of their works
- 3Biomaterials11% of their works
- 4Materials Chemistry10% of their works
- 5Oncology4% of their works
- 6Immunology4% of their works
Research topics
- Nanoplatforms for cancer theranostics
- Nanoparticle-Based Drug Delivery
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Graphene and Nanomaterials Applications
- Advanced Nanomaterials in Catalysis
- Luminescence and Fluorescent Materials
- Gold and Silver Nanoparticles Synthesis and Applications
Which keywords describe Xing‐Jie Liang's research?
The keywords of their largest research topics: Nanoparticles, Tumor Targeting, Biomedical Applications, Photodynamic Therapy, Photothermal Therapy, Cancer Therapy, Drug Delivery and Fluorescence Imaging.
- Gold Nanoparticles
- Aggregation-Induced Emission
- Nanozymes
- Graphene
- DNA nanotechnology
- RNA Interference
- Nanocarriers
- Fluorescence Imaging
- Cancer Therapy
- Photodynamic Therapy
- Tumor Targeting
- Nanoparticles
- Biomedical Applications
- Photothermal Therapy
- Drug Delivery
- Reactive Oxygen Species
- Surface Engineering
- siRNA Delivery
- Self-Assembly
- Nanomaterials
- Peroxidase-Like Activity
- Fluorescent Materials
- Plasmonic Nanoparticles
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Nanoparticles4403 topics
- Tumor Targeting3402 topics
- Biomedical Applications2814 topics
- Photodynamic Therapy2152 topics
- Photothermal Therapy2102 topics
- Cancer Therapy2092 topics
- Drug Delivery2092 topics
- Fluorescence Imaging1791 topic
- Reactive Oxygen Species1791 topic
- Nanocarriers1611 topic
- Surface Engineering1611 topic
- RNA Interference1101 topic
- siRNA Delivery1101 topic
- DNA nanotechnology1001 topic
- Self-Assembly1001 topic
- Graphene481 topic
- Nanomaterials481 topic
- Nanozymes411 topic
- Peroxidase-Like Activity411 topic
- Aggregation-Induced Emission361 topic
- Fluorescent Materials361 topic
- Gold Nanoparticles311 topic
- Plasmonic Nanoparticles311 topic
Where does Xing‐Jie Liang work?
Xing‐Jie Liang's main affiliation in the publication record is National Center for Nanoscience and Technology, China.
How many publications and citations does Xing‐Jie Liang have?
OpenAlex counts 657 works and 45,773 citations for Xing‐Jie Liang, an h-index of 115, ranking #10,531 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Xing‐Jie Liang
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Xing‐Jie Liang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.